🔹 Fortis Healthcare Delivers Robust Q1 FY26 Performance
🔹 Fortis Healthcare Delivers Robust Q1 FY26 Performance
📌 Quarter Ending June 30, 2025
Fortis Healthcare Limited reported strong financial performance for Q1 FY26, reflecting operational resilience and improved profitability.
📊 Key Financial Highlights (Standalone):
💰 Revenue from Operations: ₹43,303 Cr (↑30% YoY)
📈 EBITDA: ₹12,812 Cr | EBITDA Margin: 20.35%
🧾 Net Profit: ₹5,188 Cr (vs ₹2,683 Cr YoY)
💹 EPS: ₹0.69
✨ Exceptional Gain: ₹1,688 Cr (linked to reversal of earlier impairments)
📉 Debt/Equity: 0.23 | Interest Coverage: 2.47
🏥 Strategic and Regulatory Updates:
✅ Fortis won full rights to its own brand via court-approved auction – reinforcing identity control.
👨⚖️ Continues to cooperate fully with SFIO, SEBI, and EOW in legacy matters.
📌 Management confirms all known financial impacts already provisioned – no material risks expected.
🧮 Appointed BSR & Co. LLP as Tax Auditors for FY25.
🔍 Why This Matters:
Fortis' ability to sustain margin expansion, resolve complex legal brand matters, and maintain clean financial disclosure practices signals improving governance and long-term value creation.
📈 One of the cleaner turnaround stories in Indian healthcare space worth tracking.
